Idhifa
NDC 59572-710, enasidenib mesylate, tablet, film coated, from Celgene Corporation.
- Product NDC
- 59572-710
- Status
- Listed
- Labeler
- Celgene Corporation
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA209606
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59572-710 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ENASIDENIB MESYLATE100 mg/1
Pharmacologic classes
Isocitrate Dehydrogenase 2 Inhibitor [EPC]; Isocitrate Dehydrogenase 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59572-710-30 | 59572071030 | 30 TABLET, FILM COATED in 1 BOTTLE (59572-710-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a5b4cdf0-3fa8-4c6c-80f6-8d8a00e3a5b6
Use it
Look up 59572-710 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59572-710 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59572-710. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.